Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

References for PMC Articles for PubMed (Select 21541975)

1.

CYP17 T27C polymorphism and prostate cancer risk: a meta-analysis based on 31 studies.

Wei B, Zhang Y, Xi B, Chang J, Bai J, Su J.

J Biomed Res. 2010 May;24(3):233-41. doi: 10.1016/S1674-8301(10)60033-4.

2.

Association between ethnicity and prostate cancer outcomes across hospital and surgeon volume groups.

Jayadevappa R, Chhatre S, Johnson JC, Malkowicz SB.

Health Policy. 2011 Feb;99(2):97-106. doi: 10.1016/j.healthpol.2010.07.014. Epub 2010 Aug 13.

3.

Racial disparities in traumatic stress in prostate cancer patients: secondary analysis of a National URCC CCOP Study of 317 men.

Purnell JQ, Palesh OG, Heckler CE, Adams MJ, Chin N, Mohile S, Peppone LJ, Atkins JN, Moore DF, Spiegel D, Messing E, Morrow GR.

Support Care Cancer. 2011 Jul;19(7):899-907. doi: 10.1007/s00520-010-0880-3. Epub 2010 Apr 23.

4.
5.

Prostate cancer in African-American men and polymorphism in the calcium-sensing receptor.

Schwartz GG, John EM, Rowland G, Ingles SA.

Cancer Biol Ther. 2010 Jun 15;9(12):994-9. Epub 2010 Jun 4.

PMID:
20364112
6.
7.

Role of the adiponectin leptin ratio in prostate cancer.

Grossmann ME, Mizuno NK, Bonorden MJ, Ray A, Sokolchik I, Narasimhan ML, Cleary MP.

Oncol Res. 2009;18(5-6):269-77.

PMID:
20225764
8.

Racial differences in quality of life following prostate cancer diagnosis.

Halbert CH, Coyne J, Weathers B, Mahler B, Delmoor E, Vaughn D, Malkowicz SB, Lee D, Troxel A.

Urology. 2010 Sep;76(3):559-64. doi: 10.1016/j.urology.2009.09.090. Epub 2010 Mar 7.

9.

Racial disparities in urologic health care.

Klein JB, Nguyen CT, Saffore L, Modlin C 3rd, Modlin CS Jr.

J Natl Med Assoc. 2010 Feb;102(2):108-17.

PMID:
20191923
10.

Health disparities in staging of SEER-medicare prostate cancer patients in the United States.

Mullins CD, Onukwugha E, Bikov K, Seal B, Hussain A.

Urology. 2010 Sep;76(3):566-72. doi: 10.1016/j.urology.2009.10.061. Epub 2010 Feb 16.

11.

Racial and ethnic variation in health resource use and cost for prostate cancer.

Jayadevappa R, Malkowicz SB, Chhatre S, Gallo J, Schwartz JS.

BJU Int. 2010 Sep;106(6):801-8. doi: 10.1111/j.1464-410X.2010.09227.x. Epub 2010 Feb 11.

PMID:
20151963
12.

Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE.

Moses KA, Paciorek AT, Penson DF, Carroll PR, Master VA.

J Clin Oncol. 2010 Feb 20;28(6):1069-74. doi: 10.1200/JCO.2009.26.2469. Epub 2010 Jan 25.

13.

Interplay of race, socioeconomic status, and treatment on survival of patients with prostate cancer.

Schwartz K, Powell IJ, Underwood W 3rd, George J, Yee C, Banerjee M.

Urology. 2009 Dec;74(6):1296-302. doi: 10.1016/j.urology.2009.02.058.

14.

Patient decision aids for prostate cancer treatment: a systematic review of the literature.

Lin GA, Aaronson DS, Knight SJ, Carroll PR, Dudley RA.

CA Cancer J Clin. 2009 Nov-Dec;59(6):379-90. doi: 10.3322/caac.20039. Epub 2009 Oct 19. Review.

15.

Association of CD14 variant with prostate cancer in African American men.

Mason TE, Ricks-Santi L, Chen W, Apprey V, Joykutty J, Ahaghotu C, Kittles R, Bonney G, Dunston GM.

Prostate. 2010 Feb 15;70(3):262-9. doi: 10.1002/pros.21060.

16.

Increased low density lipoprotein and increased likelihood of positive prostate biopsy in black americans.

Moses KA, Abd TT, Goodman M, Hsiao W, Hall JA, Marshall FF, Petros JA, Issa MM.

J Urol. 2009 Nov;182(5):2219-25. doi: 10.1016/j.juro.2009.07.039. Epub 2009 Sep 16.

PMID:
19758611
17.

Obesity and cancer: the role of dysfunctional adipose tissue.

van Kruijsdijk RC, van der Wall E, Visseren FL.

Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2569-78. doi: 10.1158/1055-9965.EPI-09-0372. Epub 2009 Sep 15. Review.

18.

Prevalence and correlates of vitamin D status in African American men.

Tseng M, Giri V, Bruner DW, Giovannucci E.

BMC Public Health. 2009 Jun 18;9:191. doi: 10.1186/1471-2458-9-191.

19.

Expression of angiogenic regulators, VEGF and leptin, is regulated by the EGF/PI3K/STAT3 pathway in colorectal cancer cells.

Cascio S, Ferla R, D'Andrea A, Gerbino A, Bazan V, Surmacz E, Russo A.

J Cell Physiol. 2009 Oct;221(1):189-94. doi: 10.1002/jcp.21843.

PMID:
19492417
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk